In order to further determine the correlation between H19 expression and gliomas and verify the results from Oncomine analyses, we analyzed GEPIA data and found that H19 was significantly up-regulated in DLBC (Lymphoid Neoplasm Diffuse Large B-cell Lymphoma), GBM (glioblastoma multiforme), PAAD (pancreatic cancer), STAD (gastric cancer), and THYM (Thymoma) (Figure 6A). This evidence concerns the gene H19 and glioma.